Cargando…

Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease

SUMMARY: Calciprotein particles (CPP) are nanoscale mineralo-protein aggregates that help stabilize excess mineral in the circulation. We examined the relationship between CPP and bone mineral density in Fabry disease patients. We found an inverse correlation with total hip and femoral neck density,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruell, S., Nicholls, K. M., Hewitson, T. D., Talbot, A. S., Holt, S. G., Smith, E. R., Ruderman, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499881/
https://www.ncbi.nlm.nih.gov/pubmed/35575807
http://dx.doi.org/10.1007/s00198-022-06420-z
_version_ 1784795095794450432
author Bruell, S.
Nicholls, K. M.
Hewitson, T. D.
Talbot, A. S.
Holt, S. G.
Smith, E. R.
Ruderman, I.
author_facet Bruell, S.
Nicholls, K. M.
Hewitson, T. D.
Talbot, A. S.
Holt, S. G.
Smith, E. R.
Ruderman, I.
author_sort Bruell, S.
collection PubMed
description SUMMARY: Calciprotein particles (CPP) are nanoscale mineralo-protein aggregates that help stabilize excess mineral in the circulation. We examined the relationship between CPP and bone mineral density in Fabry disease patients. We found an inverse correlation with total hip and femoral neck density, but none with lumbar spine. PURPOSE: Calciprotein particles (CPP) are colloidal mineral-protein complexes made up primarily of the circulating glycoprotein fetuin-A, calcium, and phosphate. They form in extracellular fluid and facilitate the stabilization, transport, and clearance of excess minerals from the circulation. While most are monomers, they also exist in larger primary (CPP-I) and secondary (CPP-II) form, both of which are reported to be raised in pathological states. This study sought to investigate CPP levels in the serum of patients with Fabry disease, an X-linked systemic lysosomal storage disorder that is associated with generalized inflammation and low bone mineral density (BMD). METHODS: We compared serum CPP-I and CPP-II levels in 59 patients with Fabry disease (37 female) with levels in an age-matched healthy adult cohort (n=28) and evaluated their association with BMD and biochemical data obtained from routine clinical review. RESULTS: CPP-I and CPP-II levels were higher in male Fabry disease patients than female sufferers as well as their corresponding sex- and age-matched controls. CPP-II levels were inversely correlated with BMD at the total hip and femoral neck, but not the lumbar spine. Regression analyses revealed that these associations were independent of common determinants of BMD, but at the femoral neck, a significant association was only found in female patients. CONCLUSION: Low hip BMD was associated with high CPP-II in patients with Fabry disease, but further work is needed to investigate the relevance of sex-related differences and to establish whether CPP measurement may aid assessment of bone disease in this setting.
format Online
Article
Text
id pubmed-9499881
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer London
record_format MEDLINE/PubMed
spelling pubmed-94998812022-09-24 Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease Bruell, S. Nicholls, K. M. Hewitson, T. D. Talbot, A. S. Holt, S. G. Smith, E. R. Ruderman, I. Osteoporos Int Original Article SUMMARY: Calciprotein particles (CPP) are nanoscale mineralo-protein aggregates that help stabilize excess mineral in the circulation. We examined the relationship between CPP and bone mineral density in Fabry disease patients. We found an inverse correlation with total hip and femoral neck density, but none with lumbar spine. PURPOSE: Calciprotein particles (CPP) are colloidal mineral-protein complexes made up primarily of the circulating glycoprotein fetuin-A, calcium, and phosphate. They form in extracellular fluid and facilitate the stabilization, transport, and clearance of excess minerals from the circulation. While most are monomers, they also exist in larger primary (CPP-I) and secondary (CPP-II) form, both of which are reported to be raised in pathological states. This study sought to investigate CPP levels in the serum of patients with Fabry disease, an X-linked systemic lysosomal storage disorder that is associated with generalized inflammation and low bone mineral density (BMD). METHODS: We compared serum CPP-I and CPP-II levels in 59 patients with Fabry disease (37 female) with levels in an age-matched healthy adult cohort (n=28) and evaluated their association with BMD and biochemical data obtained from routine clinical review. RESULTS: CPP-I and CPP-II levels were higher in male Fabry disease patients than female sufferers as well as their corresponding sex- and age-matched controls. CPP-II levels were inversely correlated with BMD at the total hip and femoral neck, but not the lumbar spine. Regression analyses revealed that these associations were independent of common determinants of BMD, but at the femoral neck, a significant association was only found in female patients. CONCLUSION: Low hip BMD was associated with high CPP-II in patients with Fabry disease, but further work is needed to investigate the relevance of sex-related differences and to establish whether CPP measurement may aid assessment of bone disease in this setting. Springer London 2022-05-16 2022 /pmc/articles/PMC9499881/ /pubmed/35575807 http://dx.doi.org/10.1007/s00198-022-06420-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Article
Bruell, S.
Nicholls, K. M.
Hewitson, T. D.
Talbot, A. S.
Holt, S. G.
Smith, E. R.
Ruderman, I.
Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease
title Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease
title_full Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease
title_fullStr Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease
title_full_unstemmed Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease
title_short Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease
title_sort reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with fabry disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499881/
https://www.ncbi.nlm.nih.gov/pubmed/35575807
http://dx.doi.org/10.1007/s00198-022-06420-z
work_keys_str_mv AT bruells reducedhipbonemineraldensityisassociatedwithhighlevelsofcalciproteinparticlesinpatientswithfabrydisease
AT nichollskm reducedhipbonemineraldensityisassociatedwithhighlevelsofcalciproteinparticlesinpatientswithfabrydisease
AT hewitsontd reducedhipbonemineraldensityisassociatedwithhighlevelsofcalciproteinparticlesinpatientswithfabrydisease
AT talbotas reducedhipbonemineraldensityisassociatedwithhighlevelsofcalciproteinparticlesinpatientswithfabrydisease
AT holtsg reducedhipbonemineraldensityisassociatedwithhighlevelsofcalciproteinparticlesinpatientswithfabrydisease
AT smither reducedhipbonemineraldensityisassociatedwithhighlevelsofcalciproteinparticlesinpatientswithfabrydisease
AT rudermani reducedhipbonemineraldensityisassociatedwithhighlevelsofcalciproteinparticlesinpatientswithfabrydisease